| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/08/2005 | CN1204887C Green tea polyphenol anti-caries coating film |
| 06/08/2005 | CN1204881C Use of allylamine derivatives in the manufacture of a medicament for the treatment of helicobacter pylori infection and correlation diseases |
| 06/08/2005 | CN1204875C Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 06/08/2005 | CN1204871C High cleaning dentifrice |
| 06/08/2005 | CN1204870C Dental care compositions |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903187 Structural modification of clostridal neurotoxins including addition or deletion of a leucine-based motif to treat biological disorders include treating autonomic disorders, neuromuscular disorders and pain |
| 06/07/2005 | US6903186 Analogues of GLP-1 |
| 06/07/2005 | US6903137 Agonists specific for the peripheral cannabinoid receptor |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903122 Crystals of benzimidazole compounds |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders |
| 06/07/2005 | US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/07/2005 | US6903096 Quinazoline derivatives as medicaments |
| 06/07/2005 | US6903089 Lactam-substituted pyrazolopyridine derivatives |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/07/2005 | US6903082 Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof |
| 06/07/2005 | US6902736 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same |
| 06/07/2005 | CA2336815C Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 06/07/2005 | CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/07/2005 | CA2186039C New oral pharmaceutical dosage form |
| 06/02/2005 | WO2005016225A3 Stable pharmaceutical composition of rabeprazole |
| 06/02/2005 | WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 06/02/2005 | US20050119611 Apparatus and method for delivery of therapeutic and/or diagnostic agents |
| 06/02/2005 | US20050119450 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 06/02/2005 | US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor |
| 06/02/2005 | US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 06/02/2005 | US20050119310 nucleoside / nucleitide antiviral agents [2'-deoxy-3'-thiocytidine-5'-triphosphate (3TC)]; immunomodulators / immunostimulants; synergistic effect; prevent drug resistance; reduce toxicity |
| 06/02/2005 | US20050119298 Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 06/02/2005 | US20050119297 Use of 5HT3 agonists for relaxing the fundus |
| 06/02/2005 | US20050119277 Benzazole derivatives for the treatment of scleroderma |
| 06/02/2005 | US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use |
| 06/02/2005 | US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 06/02/2005 | US20050119255 Phenylpyrimidine amines as ige inhibitors |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119224 Use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for adjuvant treatment of perianal disease |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119204 Osteopontin-related compositions and methods |
| 06/02/2005 | US20050118289 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 06/02/2005 | DE4139840B4 Antigen-Zubereitung zum Nachweis von H. pylori Antigen preparation for the detection of H. pylori |
| 06/02/2005 | CA2546019A1 Therapeutic peg solution concentrate |
| 06/01/2005 | EP1535927A1 Hbv precore protein capable of forming particles |
| 06/01/2005 | EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 06/01/2005 | EP1535915A1 Furan or thiophene derivative and medicinal use thereof |
| 06/01/2005 | EP1535913A1 Novel quaternary ammonium compounds |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1535512A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARa GENE TRANSFERRED THEREINTO AND USE THEREOF |
| 06/01/2005 | EP1534847A1 Retroviral vector and stable packaging cell lines |
| 06/01/2005 | EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 06/01/2005 | EP1534725A2 Compounds and methods for inhibiting selectin-mediated function |
| 06/01/2005 | EP1534695A2 Tyrosine kinase inhibitors |
| 06/01/2005 | EP1534687A1 Pyrimidine compounds |
| 06/01/2005 | EP1534681A1 Substituted quinoline ccr5 receptor antagonists |
| 06/01/2005 | EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 06/01/2005 | EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 06/01/2005 | EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 06/01/2005 | EP1534322A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 06/01/2005 | EP1534321A1 Methods of use of compounds with preptin function |
| 06/01/2005 | EP1534290A2 Novel inhibitors of kinases |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534278A2 Nitrosated proton pump inhibitors, compositions and methods of use |
| 06/01/2005 | EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/01/2005 | EP1534267A1 Pyrrolidine derivatives as tryptase inhibitors |
| 06/01/2005 | EP1534261A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 06/01/2005 | EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1363603B1 Method for making water soluble a poorly water-soluble antiseptic |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors |
| 06/01/2005 | EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 06/01/2005 | EP1178977B1 Ion channel modulating agents |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 06/01/2005 | EP1049679B1 Sulphonamide derivatives for treatment of cns disorders |
| 06/01/2005 | EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 06/01/2005 | CN1622994A TGF-beta-specific covalently closed antisense molecule |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1622953A Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 06/01/2005 | CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 06/01/2005 | CN1622938A 方法 Method |
| 06/01/2005 | CN1622830A Peptide-based compounds |
| 06/01/2005 | CN1622828A Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 06/01/2005 | CN1622821A Method of stimulating growth and resistance to diseases of aquatic organisms |
| 06/01/2005 | CN1622816A Composition and method for augmenting kidney function |
| 06/01/2005 | CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound |
| 06/01/2005 | CN1622811A Use of alkylphosphocholines for the preventative treatment of protozoan diseases |
| 06/01/2005 | CN1622807A Phenylpyrimidine amines as IgE inhibitors |
| 06/01/2005 | CN1622805A Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 06/01/2005 | CN1621094A Gene transfer for regulating smooth muscle tone |
| 06/01/2005 | CN1621091A Intestine targeted formulation of PEGylated rotavirus and its synthesizing method |
| 06/01/2005 | CN1621090A Oral freeze dried formulation of specific yelk immunoglobulin and its preparation method and usage |
| 06/01/2005 | CN1621075A Chinese herbal composition for purifying and nourishing human body internal organ and its application |
| 06/01/2005 | CN1621073A Chinese traditional medicine for treating acute and chronic gastritis and stomach ulcer |
| 06/01/2005 | CN1621069A Health caring medicinal liquor for eliminating pain |